Who owns gene editing? Patents in the time of CRISPR

Research output: Contribution to journalArticlepeer-review


New gene-editing technologies, like CRISPR, promise revolutionary advances in biology and medicine. However, several patent disputes in the USA and UK may have complicated who can use CRISPR. What does this mean for the future of gene editing?. June 2016.

Original languageEnglish (US)
Pages (from-to)26-29
Number of pages4
Issue number3
StatePublished - 2016
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Who owns gene editing? Patents in the time of CRISPR'. Together they form a unique fingerprint.

Cite this